Skip to main
NNOX

Nano-X Imaging (NNOX) Stock Forecast & Price Target

Nano-X Imaging (NNOX) Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Nano X Imaging is showing improving top-line traction with growing revenue and a $35 million revenue target for 2026, supported by teleradiology growth, Nanox Health IT contribution, and expanding U.S. distribution of the Nanox.ARC. While the fourth-quarter experienced a non-cash impairment, the new distribution agreement with Imperial Imaging Technology is a significant step-up in channel scale, leveraging a national footprint and established procurement relationships to drive adoption in underserved settings. Nanox's strategy of closer-to-patient imaging is reinforced through this partnership, further supporting its commercialization thesis and potential for future growth.

Bears say

Nano X Imaging is facing challenges in converting its distribution agreements into meaningful revenue and requires additional financing for execution, making it heavily reliant on successful operation. The company's strategy of leveraging regional distributors for adoption and sales cycle reduction has shown positive signs but focused efforts on execution, especially with execution of Imperial Imaging. Furthermore, the removal of the adjunctive use limitation in the U.S. is critical for growth, as well as demonstrating broad utilization of its technology and securing additional financing.

Nano-X Imaging (NNOX) has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Nano-X Imaging (NNOX) Forecast

Analysts have given Nano-X Imaging (NNOX) a Strong Buy based on their latest research and market trends.

According to 1 analysts, Nano-X Imaging (NNOX) has a Strong Buy consensus rating as of Apr 28, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Nano-X Imaging (NNOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.